Xilio Therapeutics Funding: $95M Raised, Series C (2021)

Xilio Therapeutics funding overview

Xilio Therapeutics is a Biotech company based in Waltham. Xilio Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2021. The round record for Xilio Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors and 3 others. 9 distinct backers are named across the disclosed rounds.

Xilio Therapeutics at a glance

Total raised: $95M
Latest round: Series C
Latest round date: February 2021
Industry: Biotech
Headquarters: Waltham
Notable investors: Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors, Takeda Ventures, RiverVest Venture Partners

Frequently asked about Xilio Therapeutics funding

How much has Xilio Therapeutics raised?: Xilio Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Xilio Therapeutics?: Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors are named among the investors backing Xilio Therapeutics.
What was the latest Xilio Therapeutics funding round?: The most recent disclosed round is a Series C, announced in February 2021.
Where is Xilio Therapeutics based?: Xilio Therapeutics is based in Waltham.
What sector does Xilio Therapeutics operate in?: Xilio Therapeutics is tracked under Biotech from Waltham, with $95M in disclosed funding.
When did Xilio Therapeutics last raise?: The last disclosed Xilio Therapeutics round closed in February 2021 at Series C.

Xilio Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Waltham below to benchmark round size and investor mix.

Xilio Therapeutics Funding: $95M Raised, Series C (2021)

Xilio Therapeutics funding overview

Xilio Therapeutics at a glance

Frequently asked about Xilio Therapeutics funding

Xilio Therapeutics founders (1)

Companies related to Xilio Therapeutics (40)

Browse related funding lists (9)